Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arginine Replacement Therapy in Children Hospitalized With COVID-19
NCT05855330Phase 2Recruiting
- Sponsor
- Emory University
- Start
- Jan 2024
- Primary completion
- Jun 2028
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arginine in coronavirus disease 2019 (COVID-19), sponsored by Emory University. Started Jan 2024; status: recruiting.
02
Drugs
arginine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05855330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05855330.